Yoshiya Horimoto

51PUBLICATIONS
58CO-AUTHORS
Predictive and prognostic markersHaematological tumoursPsychosocial aspects of childbirth and perinatal mental healthCancer therapy (excl. chemotherapy and radiation therapy)Japanese language
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (51)

|Oct 27, 2026
Prognostic performance of the Japanese Breast Cancer Society pathological response classification after neoadjuvant chemotherapy.

|Sep 28, 2026
Clinical and Local Immune Factors Associated With Pleurodesis Outcomes in Breast Cancer Patients With Malignant Pleural Effusion: A Retrospective Study.

|Aug 14, 2026
Risk of febrile neutropenia in breast cancer chemotherapy despite the prophylactic use of pegfilgrastim: a retrospective analysis.

|Jul 17, 2026
IL-26-driven epigenetic remodeling promotes immune evasion in colorectal cancer.

|Jun 26, 2026
Cyclin E1 Expression Predicts Poorer Outcome in HER2-positive Breast Cancer with Residual Disease after Neoadjuvant Chemotherapy.

|May 18, 2026
Limits of substitution and context-dependent selective omission of Oncotype DX recurrence score testing.

Pageof 9

Frequent Collaborators

12 joint publications

Takashi Ishikawa

11 joint publications

Junichiro Watanabe

8 joint publications

Yumiko Ishizuka

6 joint publications

Hiroki Kusama